Douglas E. Jones
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Douglas E. Jones has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Christine Anne Petersen
University of Iowa
3 shared publications - Katherine Nicole Gibson-Corley
Vanderbilt University School of Medicine
3 shared publications - Amanda E. Ramer-Tait
University of Nebraska-Lincoln
2 shared publications Balaji Narasimhan
Department of Chemical and Biological Engineering, Iowa State University, Ames, IA 50011, United States; Nanovaccine Institute, Iowa State University, Ames, IA 50011, United States
2 shared publicationsKriscelle Mendoza
Department of Veterinary Pathology, Iowa State University, Ames, IA 50011, USA
2 shared publicationsMatthew T. Brewer
Department of Veterinary Pathology, Iowa State University, Ames, IA 50011, USA
2 shared publications
Latest Publications
- Open Access
- 3 May 2025
- Published by MDPI AG in Microorganisms
- Vol. 13  (5) , 1070
Perineal Urethrostomy Enables Susceptibility of Bull Calves as a Natural Host Model for Bovine Trichomonosis
Tritrichomonas foetus is a sexually transmitted protozoan that causes early embryonic death in cattle. A challenge in trichomonosis research is that in vivo studies of treatments, diagnostic strategies, and vaccines are severely hampered by the logistical challenge and cost of maintaining adult bulls. Since natural infections are diagnosed in postpubescent animals, the paradigm is that only mature breeding bulls can be infected. In this study, we hypothesized that prepubescent bull calves could be artificially infected with T. foetus trophozoites for the purpose of conducting research trials. Initial attempts to directly infect bull calves with two different parasite isolates resulted in the sporadic and transient detection of parasite DNA but not culturable trophozoites. In vitro and in vivo studies suggested that urine directly inhibited trophozoites, likely by osmotic damage and mechanical flushing action. Studies utilizing a perineal urethrostomy to remove urine flow from the prepuce resulted in the ability to colonize the prepuce, with live organisms being cultured for as long as 15 days post-inoculation. Future studies optimizing this technique have the potential to accelerate the pace of bovine trichomonosis research and may have applications in the study of human trichomoniasis.
- 3 May 2025
- Published by MDPI AG in Microorganisms
- Vol. 13  (5) , 1070
Open AccessPerineal Urethrostomy Enables Susceptibility of Bull Calves as a Natural Host Model for Bovine Trichomonosis
Tritrichomonas foetus is a sexually transmitted protozoan that causes early embryonic death in cattle. A challenge in trichomonosis research is that in vivo studies of treatments, diagnostic strategies, and vaccines are severely hampered by the logistical challenge and cost of maintaining adult bulls. Since natural infections are diagnosed in postpubescent animals, the paradigm is that only mature breeding bulls can be infected. In this study, we hypothesized that prepubescent bull calves could be artificially infected with T. foetus trophozoites for the purpose of conducting research trials. Initial attempts to directly infect bull calves with two different parasite isolates resulted in the sporadic and transient detection of parasite DNA but not culturable trophozoites. In vitro and in vivo studies suggested that urine directly inhibited trophozoites, likely by osmotic damage and mechanical flushing action. Studies utilizing a perineal urethrostomy to remove urine flow from the prepuce resulted in the ability to colonize the prepuce, with live organisms being cultured for as long as 15 days post-inoculation. Future studies optimizing this technique have the potential to accelerate the pace of bovine trichomonosis research and may have applications in the study of human trichomoniasis.
- Open Access
Delivering an Immunocastration Vaccine via a Novel Subcutaneous Implant
Immunocastration relies on the vaccine-mediated stimulation of an immune response to gonadotropin-releasing hormone (GnRH) in order to interrupt spermatogenesis. This approach offers a less painful alternative to traditional castration approaches but the current, commercially available options require multiple doses of vaccine to maintain sterility. Thus, a series of pilot studies were conducted to determine the feasibility of a single-dose immunocastration vaccine implant. These five studies utilized a total of 44 Holstein bulls to determine the optimal vaccine composition and validate the ability of a stainless-steel subcutaneous implant to deliver a vaccine. Outcome measures included the duration of implant retention, scrotal dimensions and temperature, implant site temperature, anti-GnRH antibodies, and serum testosterone concentration. Over the course of several studies, anti-GnRH antibodies were successfully stimulated by vaccine implants. No significant treatment effects on scrotal dimensions or testosterone were detected over time, but changes in spermatogenesis were detected across treatment groups. Results indicate that a single-dose implantable immunocastration vaccine elicits a humoral immune response and could impact spermatogenesis in bulls. These findings provide opportunities for the refinement of this technology to improve implant retention over longer periods of time. Taken together, this approach will offer producers and veterinarians an alternative to physical castration methods, to improve animal welfare during routine livestock management procedures.
Open AccessDelivering an Immunocastration Vaccine via a Novel Subcutaneous Implant
Immunocastration relies on the vaccine-mediated stimulation of an immune response to gonadotropin-releasing hormone (GnRH) in order to interrupt spermatogenesis. This approach offers a less painful alternative to traditional castration approaches but the current, commercially available options require multiple doses of vaccine to maintain sterility. Thus, a series of pilot studies were conducted to determine the feasibility of a single-dose immunocastration vaccine implant. These five studies utilized a total of 44 Holstein bulls to determine the optimal vaccine composition and validate the ability of a stainless-steel subcutaneous implant to deliver a vaccine. Outcome measures included the duration of implant retention, scrotal dimensions and temperature, implant site temperature, anti-GnRH antibodies, and serum testosterone concentration. Over the course of several studies, anti-GnRH antibodies were successfully stimulated by vaccine implants. No significant treatment effects on scrotal dimensions or testosterone were detected over time, but changes in spermatogenesis were detected across treatment groups. Results indicate that a single-dose implantable immunocastration vaccine elicits a humoral immune response and could impact spermatogenesis in bulls. These findings provide opportunities for the refinement of this technology to improve implant retention over longer periods of time. Taken together, this approach will offer producers and veterinarians an alternative to physical castration methods, to improve animal welfare during routine livestock management procedures.
- 1 November 2016
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 180, 40-44
Macrophage effector responses of horses are influenced by expression of CD154
- 1 November 2016
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 180, 40-44
Macrophage effector responses of horses are influenced by expression of CD154
- Open Access
- 5 September 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9  (9) , e106426
An In Vitro Model of Antibody-Enhanced Killing of the Intracellular Parasite Leishmania amazonensis
Footpad infection of C3HeB/FeJ mice with Leishmania amazonensis leads to chronic lesions accompanied by large parasite loads. Co-infecting these animals with L. major leads to induction of an effective Th1 immune response that can resolve these lesions. This cross-protection can be recapitulated in vitro by using immune cells from L. major-infected animals to effectively activate L. amazonensis-infected macrophages to kill the parasite. We have shown previously that the B cell population and their IgG2a antibodies are required for effective cross-protection. Here we demonstrate that, in contrast to L. major, killing L. amazonensis parasites is dependent upon FcRγ common-chain and NADPH oxidase-generated superoxide from infected macrophages. Superoxide production coincided with killing of L. amazonensis at five days post-activation, suggesting that opsonization of the parasites was not a likely mechanism of the antibody response. Therefore we tested the hypothesis that non-specific immune complexes could provide a mechanism of FcRγ common-chain/NADPH oxidase dependent parasite killing. Macrophage activation in response to soluble IgG2a immune complexes, IFN-γ and parasite antigen was effective in significantly reducing the percentage of macrophages infected with L. amazonensis. These results define a host protection mechanism effective during Leishmania infection and demonstrate for the first time a novel means by which IgG antibodies can enhance killing of an intracellular pathogen.
- 5 September 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9  (9) , e106426
Open AccessAn In Vitro Model of Antibody-Enhanced Killing of the Intracellular Parasite Leishmania amazonensis
Footpad infection of C3HeB/FeJ mice with Leishmania amazonensis leads to chronic lesions accompanied by large parasite loads. Co-infecting these animals with L. major leads to induction of an effective Th1 immune response that can resolve these lesions. This cross-protection can be recapitulated in vitro by using immune cells from L. major-infected animals to effectively activate L. amazonensis-infected macrophages to kill the parasite. We have shown previously that the B cell population and their IgG2a antibodies are required for effective cross-protection. Here we demonstrate that, in contrast to L. major, killing L. amazonensis parasites is dependent upon FcRγ common-chain and NADPH oxidase-generated superoxide from infected macrophages. Superoxide production coincided with killing of L. amazonensis at five days post-activation, suggesting that opsonization of the parasites was not a likely mechanism of the antibody response. Therefore we tested the hypothesis that non-specific immune complexes could provide a mechanism of FcRγ common-chain/NADPH oxidase dependent parasite killing. Macrophage activation in response to soluble IgG2a immune complexes, IFN-γ and parasite antigen was effective in significantly reducing the percentage of macrophages infected with L. amazonensis. These results define a host protection mechanism effective during Leishmania infection and demonstrate for the first time a novel means by which IgG antibodies can enhance killing of an intracellular pathogen.
- 25 August 2011
- Published by Springer Nature
- p. 85-98
B Cell-Mediated Regulation of Immunity During Leishmania Infection
- 25 August 2011
- Published by Springer Nature
- p. 85-98
B Cell-Mediated Regulation of Immunity During Leishmania Infection
- 7 February 2010
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 262  (3) , 398-412
Parameter estimation and sensitivity analysis in an agent-based model of Leishmania major infection
- 7 February 2010
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 262  (3) , 398-412
Parameter estimation and sensitivity analysis in an agent-based model of Leishmania major infection
- 1 February 2010
- Published by Elsevier in International Journal for Parasitology
- Vol. 40  (2) , 157-161
A deficiency in the B cell response of C57BL/6 mice correlates with loss of macrophage-mediated killing of Leishmania amazonensis
- 1 February 2010
- Published by Elsevier in International Journal for Parasitology
- Vol. 40  (2) , 157-161
A deficiency in the B cell response of C57BL/6 mice correlates with loss of macrophage-mediated killing of Leishmania amazonensis
- Open Access
- 1 March 2006
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 74  (3) , 1547-1554
Antigen-Responsive CD4+T Cells from C3H Mice Chronically Infected withLeishmania amazonensisAre Impaired in the Transition to an Effector Phenotype
C3HeB/FeJ mice challenged withLeishmania majordevelop a polarized Th1 response and subsequently heal, whereasLeishmania amazonensischallenge leads to chronic lesions with high parasite loads at 10 weeks postinfection. In this study, a comparison of draining lymph node cells fromL. amazonensis- andL. major-infected mice at 10 weeks postinfection showed equivalent percentages of effector/memory phenotype CD44hiCD4+T cells producing interleukin-2 (IL-2) and proliferating after antigen stimulation. However, these cells isolated fromL. amazonensis-infected mice were not skewed toward either a Th1 or Th2 phenotype in vivo, as evidenced by their unbiased Th1/Th2 transcription factor mRNA profile. In vivo antigen stimulation with added IL-12 failed to enhance gamma interferon (IFN-γ) production of CD4+T cells fromL. amazonensis-infected mice. Antigen stimulation of CD4+T cells fromL. amazonensis-infected mice in vitro in the presence of IL-12 resulted in production of only 10 to 15% of the IFN-γ produced by T cells fromL. major-infected mice under identical conditions. These results suggest that the CD4+T-cell response during chronicL. amazonensisinfection is limited during the transition from an early activated CD4+T-cell population to an effector cell population and demonstrate that these T cells have an intrinsic defect beyond the presence or absence of IL-12 during antigen stimulation.
- 1 March 2006
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 74  (3) , 1547-1554
Open AccessAntigen-Responsive CD4+T Cells from C3H Mice Chronically Infected withLeishmania amazonensisAre Impaired in the Transition to an Effector Phenotype
C3HeB/FeJ mice challenged withLeishmania majordevelop a polarized Th1 response and subsequently heal, whereasLeishmania amazonensischallenge leads to chronic lesions with high parasite loads at 10 weeks postinfection. In this study, a comparison of draining lymph node cells fromL. amazonensis- andL. major-infected mice at 10 weeks postinfection showed equivalent percentages of effector/memory phenotype CD44hiCD4+T cells producing interleukin-2 (IL-2) and proliferating after antigen stimulation. However, these cells isolated fromL. amazonensis-infected mice were not skewed toward either a Th1 or Th2 phenotype in vivo, as evidenced by their unbiased Th1/Th2 transcription factor mRNA profile. In vivo antigen stimulation with added IL-12 failed to enhance gamma interferon (IFN-γ) production of CD4+T cells fromL. amazonensis-infected mice. Antigen stimulation of CD4+T cells fromL. amazonensis-infected mice in vitro in the presence of IL-12 resulted in production of only 10 to 15% of the IFN-γ produced by T cells fromL. major-infected mice under identical conditions. These results suggest that the CD4+T-cell response during chronicL. amazonensisinfection is limited during the transition from an early activated CD4+T-cell population to an effector cell population and demonstrate that these T cells have an intrinsic defect beyond the presence or absence of IL-12 during antigen stimulation.